Table 2.
Strains | Features and References | |
---|---|---|
Escherichia coli | ||
ATCC10536 | Reference strain | |
AG100 | Wild-type E. coli K-12 | [54] |
AG100A | AG100 ΔacrAB::KANR | [34, 54, 55] |
AG100ATET | ΔacrAB mutant AG100, with over-expressing acrF gene; TETR | [54] |
AG102 | ΔacrAB mutant AG100, owing acrF gene markedly over-expressed; TETR | [56, 57] |
MC4100 | Wild type E. coli | [58] |
W3110 | Wild type E. coli | [58, 59] |
Enterobacter aerogenes | ||
ATCC13048 | Reference strains | |
CM64 | CHLR resistant variant obtained from ATCC13048 over-expressing the AcrAB pump | [60] |
EA3 | Clinical MDR isolate; CHLR, NORR, OFXR, SPXR, MOXR, CFTR, ATMR, FEPR | [61, 62] |
EA27 | Clinical MDR isolate exhibiting energy-dependent norfloxacin and chloramphenicol efflux with KANR AMPR NALR STRR TETR | [61, 62] |
EA289 | KAN sensitive derivative of EA27 | [63] |
EA294 | EA289 acrA::KANR | [63] |
EA298 | EA 289 tolC::KANR | [63] |
Enterobacter cloacae | ||
ECCI69 | Clinical MDR isolates, CHLR | [7] |
BM67 | Clinical MDR isolates, CHLR | [7] |
Klebsiella pneumoniae | ||
ATCC12296 | Reference strains | |
KP55 | Clinical MDR isolate, TETR, AMPR, ATMR, CEFR | [64] |
KP63 | Clinical MDR isolate, TETR, CHLR, AMPR, ATMR | [64] |
K24 | AcrAB-TolC, Laboratory collection of UNR-MD1, University of Marseille, France | [7] |
K2 | AcrAB-TolC, Laboratory collection of UNR-MD1, University of Marseille, France | [7] |
Providencia stuartii | [65] | |
NEA16 | Clinical MDR isolate, AcrAB-TolC | |
ATCC29916 | Clinical MDR isolate, AcrAB-TolC | |
PS2636 | Clinical MDR isolate, AcrAB-TolC | |
PS299645 | Clinical MDR isolate, AcrAB-TolC | |
Pseudemonas aeruginosa | ||
PA 01 | Reference strains | |
PA 124 | MDR clinical isolate | [66] |
aAMP, ATMR, CEFR, CFTR, CHLR, FEPR, KANR, MOXR, STRR, TETR. Resistance to ampicillin, aztreonam, cephalothin, cefadroxil, chloramphenicol, cefepime, kanamycin, moxalactam, streptomycin, and tetracycline; MDR Multidrug resistant